Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook.

Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook.
复制标题

DOI:
10.1016/j.mayocp.2020.10.011
复制
发表时间:
2020-12
影响因子:
8.9
通讯作者:
Gold MS
Gold MS
中科院分区:
医学2区
文献类型:
--
作者:
Oesterle TS;Kolla B;Risma CJ;Breitinger SA;Rakocevic DB;Loukianova LL;Hall-Flavin DK;Gentry MT;Rummans TA;Chauhan M;Gold MS

文献摘要

参考文献

被引文献

相似文献

在当前的2019年冠状病毒病疫情期间,许多门诊化学依赖治疗项目和诊所正在减少与患者接触的人数。这扩大了需要治疗的物质使用障碍患者与实际接受治疗的患者之间已经很大的差距。对于一种几十年来一直以团体治疗为主要治疗选择的疾病来说,社交距离、庇护所和治疗中止已经迫切需要替代成瘾治疗的方法。为了继续为有需要的患者提供一些护理,许多医疗机构已经过渡到虚拟环境,以促进安全的社交距离。虽然有充分的证据支持远程医疗干预措施,但这些措施可能难以实施,特别是在南方城市人口中。本文回顾了目前的文献中使用的远程医疗干预治疗SUD,并提供了安全和有效的实施策略的基础上,目前的文献的建议。
During the current coronavirus disease 2019 epidemic, many outpatient chemical dependency treatment programs and clinics are decreasing their number of in-person patient contacts. This has widened an already large gap between patients with substance use disorders (SUDs) who need treatment and those who have actually received treatment. For a disorder where group therapy has been the mainstay treatment option for decades, social distancing, shelter in place, and treatment discontinuation have created an urgent need for alternative approaches to addiction treatment. In an attempt to continue some care for patients in need, many medical institutions have transitioned to a virtual environment to promote safe social distancing. Although there is ample evidence to support telemedical interventions, these can be difficult to implement, especially in the SUD population. This article reviews current literature for the use of telehealth interventions in the treatment of SUDs and offers recommendations on safe and effective implementation strategies based on the current literature.
DOI: 10.1080/08897077.2013.821437
发表时间: 2014
期刊: Substance abuse
影响因子: 3.5
作者:
Dulin PL;Gonzalez VM;Campbell K
通讯作者: Campbell K
DOI: 10.1016/j.jsat.2013.08.004
发表时间: 2014-01-01
影响因子: 3.9
作者:
Chih, Ming-Yuan;Patton, Timothy;Gustafson, David H.
通讯作者: Gustafson, David H.
DOI: 10.1016/j.drugalcdep.2017.01.048
发表时间: 2017-07-01
影响因子: 4.2
作者:
Eibl, Joseph K.;Gauthier, Graham;Marsh, David C.
通讯作者: Marsh, David C.
DOI: 10.1089/tmj.2013.0222
发表时间: 2014-10-01
影响因子: 4.7
作者:
Giroux, Danielle;Bacon, Samantha;Gonzalez, Vivian
通讯作者: Gonzalez, Vivian
DOI: 10.1016/j.addbeh.2008.05.004
发表时间: 2008-09-01
影响因子: 4.4
作者:
Cacciola, John S.;Camilleri, Amy C.;Schwarzlose, John T.
通讯作者: Schwarzlose, John T.